Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT2016092624021N2Phase 2Completed
Phase 2 trial of levothyroxine sodium in benign thyroid nodule, sponsored by Guilan University of Medical Sciences. Primary endpoint: Change in benign thyroid nodule volume. Started Sep 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT2016092624021N2.